Ultrasound AI's Robert Bunn Clinches Top Prize at Cooley Capital Call Pitch Competition

Robert Bunn Wins Prestigious Award at Cooley Capital Call

On May 5, 2026, Ultrasound AI announced a significant achievement for its founder, Robert Bunn, who clinched the top prize at the Cooley Capital Call pitch competition. This competition took place during the highly regarded Digital Healthcare Innovation Summit held in Boston from April 27-28.

Selected from a highly competitive field, Ultrasound AI was one of only seven companies invited to pitch. The Cooley Capital Call adopted a rapid-fire pitching format, allowing founders just three minutes to present their innovative ideas, followed by a live Q&A session with a panel of judges, including venture capitalists, legal experts, and seasoned startup founders.

In his presentation, Bunn articulated Ultrasound AI's ambitious vision to revolutionize prenatal care through their FDA-cleared technology, Delivery Date AI™. He also discussed the company's roadmap and plans to raise $25 million in Series A funding. Winning the competition is a significant endorsement from a prominent network within the innovation and funding space, showcasing Ultrasound AI's potential.

Bunn expressed enthusiasm about the recognition, stating, "This recognition reflects the urgency of improving maternal health and the opportunity for AI to make a meaningful impact. We are building technology that empowers clinicians and instills confidence in expectant mothers, and it's gratifying to know that our vision resonates with leading investors and industry experts."

This notable win adds to the growing momentum surrounding Ultrasound AI, particularly after receiving FDA De Novo clearance for Delivery Date AI™. This innovative product harnesses the power of AI to enhance the accuracy of pregnancy dating, serving as a crucial tool for clinicians in making informed decisions.

Bunn's recognition at the Cooley Capital Call comes as the company continues to advance its mission of modernizing obstetric care through clinically validated and scalable solutions. The positive feedback and validation from the panel only serve to strengthen their resolve in developing technologies that address critical gaps in maternal healthcare, especially in the face of ongoing challenges in this field.

Looking ahead, Robert Bunn is slated to speak at Women’s Health Week USA on May 13-14 in New York City, where he will delve into the role of AI in closing longstanding gaps about maternal healthcare. His insights will be invaluable, given the ongoing focus on utilizing technology to enhance health outcomes for mothers and their children.

About Ultrasound AI

Ultrasound AI is at the forefront of healthcare technology, dedicated to improving maternal and fetal outcomes through advanced artificial intelligence applications. The company’s flagship product, Delivery Date AI™, utilizes sophisticated algorithms to boost the accuracy of pregnancy dating, allowing clinicians to optimize care and facilitate better health outcomes for expectant mothers. As the company grows, it remains committed to delivering transformative solutions that can reshape the landscape of maternal health.

For more information or media inquiries, please connect with Ultrasound AI at [email protected]